Drug resistance in yeasts — an emerging scenario-Reference-Cited by-同舟云学术

Drug resistance in yeasts — an emerging scenario

Published:2002 Issue: Volume: Page:155-201
ISSN:0065-2911
Container-title:Advances in Microbial Physiology
language:
Short-container-title:

Author:

Prasad Rajendra,Lata Panwar Sneh,Smriti

Publisher

Elsevier

Reference222 articles.

1. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans;Alarco;J. Bacteriol.,1999

2. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLRI encoding a transporter of the major facilitator superfamily;Alarco;J. Biol. Chem.,1997

3. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance;Albertson;Antimicrob. Agents Chemother.,1996

4. Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells;Ambudkar;Methods Enzymol.,1998

5. Partial purification and reconstitution of the human multidrug-resistance pump: Characterisation of the drug-stimulatable ATP hydrolysis;Ambudkar,1992

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine-Derived Metabolites Act as Promising Antifungal Agents;Marine Drugs;2024-04-17

2. Chromatin accessibility of Meyerozyma guilliermondii under patulin stress;Biological Control;2022-09

3. Phytopharmaceuticals for the Management of Fungal Infections;Herbal Drugs for the Management of Infectious Diseases;2022-08

4. Yeast Cells in Microencapsulation. General Features and Controlling Factors of the Encapsulation Process;Molecules;2021-05-24

5. Octyl gallate reduces ABC multidrug transporter CaCdr1p expression and leads to its mislocalisation in azole-resistant clinical isolates of Candida albicans;Journal of Global Antimicrobial Resistance;2020-09